Delivery Order SPE2DE24DA010-SPE2D625F58CG

Award Date 1/31/25
Potential Completion Date 2/5/25
Potential Value $25K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Defense Logistics Agency (DLA). The $25,715.85 fixed-price delivery order is for the provision of cardiovascular medical devices and related services, including items such as stents, pacemakers, heart valves, and surgical implants. The contract has an ultimate completion date of May 2, 2025. Abbott Laboratories Inc. is the prime contractor and has established itself as a critical supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
This federal contract award, valued at $25,875.85, was made by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract is a delivery order for the provision of cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company that specializes in medical devices, diagnostics, and pharmaceuticals. The award is a delivery order contract with a fixed price and economic price adjustment mechanism. The contract has no set-aside designation, indicating full and open competition. The contract requires Abbott Laboratories Inc., through its Abbott Vascular Inc. division,...
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, by the Defense Logistics Agency (DLA) and Department of Veterans Affairs (VA). The contract has an award value of $25,715.85 and is a firm fixed-price delivery order with economic price adjustment. The contract covers the delivery of a variety of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and...
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The award has a ceiling value of $21,425.00 and is a fixed-price delivery order contract with economic price adjustment, awarded by the Defense Logistics Agency (DLA), which supports the Department of Defense (DoD) and other federal healthcare systems. The contract covers a range of specialized...
This federal contract award, valued at $1,262.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a multinational pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract is a fixed-price delivery order with economic price adjustment, with a period of performance ending on March 27, 2025. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a key supplier of advanced...
This federal contract award, valued at $28,350.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer. The award is a delivery order contract for cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. This contract supports the Department of Veterans Affairs (VA) and Defense...
This federal contract award, valued at $10,124, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. and its Abbott Vascular Inc. division. The contract is a Delivery Order for the provision of advanced cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F58CG
    Delivery Order

This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract, valued at $25,364.85, was awarded by the Defense Logistics Agency (DLA) and is a fixed-price delivery order contract with economic price adjustment. The contract has a completion date of February 5, 2025 and does not include a set-aside designation, indicating full and open competition.

Abbott Laboratories Inc. has a history of securing federal contract awards, primarily from the Department of Veterans Affairs (VA) and DLA, for the provision of a comprehensive range of cardiovascular medical devices and technologies. This award is part of the company's broader work supporting federal healthcare systems, including the delivery of products such as stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract is likely part of the company's Indefinite Delivery Contracts (IDCs) with the VA and DLA, which facilitate streamlined procurement of critical medical equipment and supplies across federal healthcare facilities.

Generated 5/14/25, 9:43 AM